Citadel Advisors’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-340,103
| Closed | -$2.29M | – | 6371 |
|
|
2025
Q1 | $2.29M | Buy |
340,103
+244,237
| +255% | +$1.64M | ﹤0.01% | 2471 |
|
|
2024
Q4 | $1.02M | Buy |
+95,866
| New | +$1.02M | ﹤0.01% | 3231 |
|
|
2024
Q3 | – | Sell |
-4,167
| Closed | -$50.4K | – | 6214 |
|
|
2024
Q2 | $50.4K | Buy |
+4,167
| New | +$50.4K | ﹤0.01% | 5175 |
|
|
2024
Q1 | – | Sell |
-2,630
| Closed | -$28.1K | – | 6456 |
|
|
2023
Q4 | $28.1K | Sell |
2,630
-4,863
| -65% | -$52K | ﹤0.01% | 5290 |
|
|
2023
Q3 | $62.6K | Buy |
7,493
+6,394
| +582% | +$53.4K | ﹤0.01% | 4998 |
|
|
2023
Q2 | $8.69K | Sell |
1,099
-1,841
| -63% | -$14.6K | ﹤0.01% | 5397 |
|
|
2023
Q1 | $14.7K | Buy |
+2,940
| New | +$14.7K | ﹤0.01% | 5452 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6370 |
|
|
2022
Q3 | – | Sell |
-13,159
| Closed | -$42K | – | 6267 |
|
|
2022
Q2 | $42K | Buy |
+13,159
| New | +$42K | ﹤0.01% | 5554 |
|
|
2022
Q1 | – | Sell |
-21,216
| Closed | -$275K | – | 6716 |
|
|
2021
Q4 | $275K | Buy |
21,216
+2,868
| +16% | +$37.2K | ﹤0.01% | 5187 |
|
|
2021
Q3 | $447K | Buy |
+18,348
| New | +$447K | ﹤0.01% | 4649 |
|